Using insurance claims and workplace productivity data from large US employers, the researchers, led by scientists from ...
Paxlovid linked to fewer lost workdays, disability claims in employees at high-risk for severe COVID
Treatment with the antiviral combination nirmatrelvir–ritonavir (Paxlovid) was associated with fewer lost workdays and lower ...
Gepotidacin, developed by GSK, will provide another alternative oral treatment option for gonorrhea patients who don’t like ...
The more severe an employee’s symptoms, the less likely they were to continue to work. HCP reporting shortness of breath had ...
An analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) highlights persistent health ...
Monthly absence-related costs per treated worker were $434 versus $468 in their untreated counterparts, and daily costs were ...
A pair of analyses on the effects of COVID-related public health measures on children ties lockdowns and physical distancing to developmental delays among toddlers in Scotland and school reopenings to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback